Schizophrenia and oxidative stress: Glutamate cysteine ligase modifier as a susceptibility gene

213Citations
Citations of this article
103Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Oxidative stress could be involved in the pathophysiology of schizophrenia, a major psychiatric disorder. Glutathione (GSH), a redox regulator, is decreased in patients' cerebrospinal fluid and prefrontal cortex. The gene of the key GSH-synthesizing enzyme, glutamate cysteine ligase modifier (GCLM) subunit, is strongly associated with schizophrenia in two case-control studies and in one family study. GCLM gene expression is decreased in patients' fibroblasts. Thus, GSH metabolism dysfunction is proposed as one of the vulnerability factors for schizophrenia. © 2006 by The American Society of Human Genetics. All rights reserved.

Cite

CITATION STYLE

APA

Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., … Do, K. Q. (2006). Schizophrenia and oxidative stress: Glutamate cysteine ligase modifier as a susceptibility gene. American Journal of Human Genetics, 79(3), 586–592. https://doi.org/10.1086/507566

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free